Version 5.4
Bos taurus Gene: LRFN3
Summary
InnateDB Gene IDBG-636056.3
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol LRFN3
Gene Name Leucine-rich repeat and fibronectin type-III domain-containing protein 3
Synonyms
Species Bos taurus
Ensembl Gene ENSBTAG00000000153
Encoded Proteins
IDBP-687946
Leucine-rich repeat and fibronectin type-III domain-containing protein 3
Protein Structure
Useful resources Stemformatics EHFPI ImmGen
Entrez Gene
Summary This gene does not have any Entrez summary - the following is the summary from its human ortholog ENSG00000126243:
Gene Information
Type Protein coding
Genomic Location Chromosome 18:46818878-46825746
Strand Forward strand
Band
Transcripts
ENSBTAT00000000176 ENSBTAP00000000176
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
Gene Ontology

Molecular Function
Accession GO Term
GO:0005515 protein binding
Biological Process
GO:0007155 cell adhesion
Cellular Component
GO:0005886 plasma membrane
GO:0016020 membrane
GO:0016021 integral component of membrane
GO:0030054 cell junction
GO:0030424 axon
GO:0030425 dendrite
GO:0042734 presynaptic membrane
GO:0042995 cell projection
GO:0045202 synapse
GO:0045211 postsynaptic membrane
Orthologs
Species
Homo sapiens
Mus musculus
Gene ID
Gene Order
ENSG00000126243
View Gene Order
ENSMUSG00000036957
View Gene Order
Cross-References
SwissProt Q1RMS4
TrEMBL
UniProt Splice Variant
Entrez Gene 767839
UniGene Bt.55363
RefSeq NM_001076959 XM_005219033
HUGO
OMIM
CCDS
HPRD
IMGT
EMBL BC114740
GenPept AAI14741
RNA Seq Atlas 767839

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca